Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.9bn2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥16.9bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2022-01-01 → 2022-03-31Cons.Net sales
Operating income¥851m2023-01-01 → 2023-03-31Cons.Operating income
Operating income¥679m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income¥961m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥2.8bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥824m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥820m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥824m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥511m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥563m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥509m2023-01-01 → 2023-03-31Cons.Profit loss
Net income¥559m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥26.7bnat 2023-03-31Cons.Assets
Total assets¥26.3bnat 2022-12-31Cons.Assets
Total assets¥24.6bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥7.2bnat 2023-03-31Cons.Liabilities
Total liabilities¥6.8bnat 2022-12-31Cons.Liabilities
Net assets / equity¥19.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥19.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥18.8bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥8.2bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥8.9bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥7.242023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.752022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.932022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥7.222023-01-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.662022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥7.912022-01-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio72.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Otherother segmentsrevenue2023-01-01 → 2023-03-31¥187m
Otherother segmentsrevenue external2023-01-01 → 2023-03-31¥167m
Otherother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥19m
Otherother segmentssegment profit2023-01-01 → 2023-03-31¥2m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥13m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥108m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥51m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥5m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥892m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥24m
—segment totalsegment profit2023-01-01 → 2023-03-31¥838m
Otherother segmentsrevenue2022-01-01 → 2022-03-31¥172m
Otherother segmentsrevenue external2022-01-01 → 2022-03-31¥163m
Otherother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥8m
Otherother segmentssegment profit2022-01-01 → 2022-03-31−¥9m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥10m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥10m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31¥5m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥136m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥136m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥27m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥538m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥538m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥95m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥3.1bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥3.1bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥2m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥751m
—segment totalrevenue2022-01-01 → 2022-03-31¥4.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥4.0bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥10m
—segment totalsegment profit2022-01-01 → 2022-03-31¥673m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Foreign currency translation adjustmentPrior1YearInstant85000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant94000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-26000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-23000000JPY
Valuation and translation adjustmentsPrior1YearInstant94000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant120000000JPY
Subscription rights to sharesPrior1YearInstant55000000JPY
Subscription rights to sharesCurrentQuarterInstant56000000JPY
Non controlling interestsPrior1YearInstant23000000JPY
Non controlling interestsCurrentQuarterInstant21000000JPY
Net assetsPrior1YearInstant19503000000JPY
Net assetsCurrentQuarterInstant19468000000JPY
Liabilities and net assetsPrior1YearInstant26349000000JPY
Liabilities and net assetsCurrentQuarterInstant26684000000JPY
Net salesPrior1YTDDuration3985000000JPY
Net salesCurrentYTDDuration4877000000JPY
Cost of salesPrior1YTDDuration1930000000JPY
Cost of salesCurrentYTDDuration2232000000JPY
Gross profitPrior1YTDDuration2054000000JPY
Gross profitCurrentYTDDuration2645000000JPY
Selling general and administrative expensesPrior1YTDDuration1375000000JPY
Selling general and administrative expensesCurrentYTDDuration1793000000JPY
Operating incomePrior1YTDDuration679000000JPY
Operating incomeCurrentYTDDuration851000000JPY
Interest income noiPrior1YTDDuration0JPY
Interest income noiCurrentYTDDuration1000000JPY
Rent income of real estate noiPrior1YTDDuration258000000JPY
Rent income of real estate noiCurrentYTDDuration251000000JPY
Other noiPrior1YTDDuration3000000JPY
Other noiCurrentYTDDuration5000000JPY
Non operating incomePrior1YTDDuration263000000JPY
Non operating incomeCurrentYTDDuration258000000JPY
Interest expenses noePrior1YTDDuration4000000JPY
Interest expenses noeCurrentYTDDuration3000000JPY
Rent expenses on real estates noePrior1YTDDuration110000000JPY
Rent expenses on real estates noeCurrentYTDDuration108000000JPY
Equity in losses of affiliates noePrior1YTDDuration-JPY
Equity in losses of affiliates noeCurrentYTDDuration35000000JPY
Other noePrior1YTDDuration2000000JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration117000000JPY
Non operating expensesCurrentYTDDuration148000000JPY
Ordinary incomePrior1YTDDuration824000000JPY
Ordinary incomeCurrentYTDDuration961000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration0JPY
Loss on step acquisitions elPrior1YTDDuration-JPY
Loss on step acquisitions elCurrentYTDDuration140000000JPY
Extraordinary lossPrior1YTDDuration0JPY
Extraordinary lossCurrentYTDDuration141000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass